About Nob Hill Therapeutics
Nob Hill Therapeutics is a company based in Albuquerque (United States) founded in 2016. Nob Hill Therapeutics has raised $3.67 million across 11 funding rounds from investors including HHS, Tramway Ventures and TCA Venture Group. Nob Hill Therapeutics offers products and services including Inhalation Medicines and Respiratory Therapies. Nob Hill Therapeutics operates in a competitive market with competitors including MannKind Corp, Impel NeuroPharma, Alexza, OptiNose and Qnovia, among others.
- Headquarter Albuquerque, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3.67 M (USD)
in 11 rounds
-
Latest Funding Round
$3 M (USD), Series A
Aug 06, 2024
-
Investors
HHS
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Nob Hill Therapeutics
Nob Hill Therapeutics offers a comprehensive portfolio of products and services, including Inhalation Medicines and Respiratory Therapies.
Develops innovative medicines for high-dose lung delivery.
Creates technologies for treating lung-related diseases.
People of Nob Hill Therapeutics
Unlock access to complete
Unlock access to complete
Funding Insights of Nob Hill Therapeutics
Nob Hill Therapeutics has successfully raised a total of $3.67M across 11 strategic funding rounds. The most recent funding activity was a Series A round of $3 million completed in August 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Nob Hill Therapeutics
Nob Hill Therapeutics has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, Tramway Ventures and TCA Venture Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are focused on life sciences companies.
|
Locked | Locked | Locked | |
|
High-impact life science companies are developed by VIC Tech.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Nob Hill Therapeutics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nob Hill Therapeutics
Investment portfolio details for Nob Hill Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Nob Hill Therapeutics
Detailed financials for Nob Hill Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nob Hill Therapeutics Comparisons
Peer comparison for Nob Hill Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Nob Hill Therapeutics
Nob Hill Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MannKind Corp, Impel NeuroPharma, Alexza, OptiNose and Qnovia, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of small-molecule drugs
|
|
| Locked | Locked | Locked |
Intranasal delivery technology for CNS diseases is developed.
|
|
| Locked | Locked | Locked |
Developer of products for the treatment of acute and intermittent conditions
|
|
| Locked | Locked | Locked |
Developer of smart devices for nasal drug delivery
|
|
| Locked | Locked | Locked |
Inhaled drug delivery devices are developed for pharmaceuticals.
|
|
| Locked | Locked | Locked |
Therapeutics for cardiopulmonary diseases are developed using inhaled therapies.
|
Detailed competitors of Nob Hill Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nob Hill Therapeutics
Complete news archive for Nob Hill Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nob Hill Therapeutics
Nob Hill Therapeutics was founded in 2016 and raised its 1st funding round 2 years after it was founded.
Nob Hill Therapeutics is headquartered in Albuquerque, United States. It is registered at Albuquerque, New Mexico, United States.
Nob Hill Therapeutics is a funded company, having raised a total of $3.67M across 11 funding rounds to date.
Nob Hill Therapeutics was founded in 2016 in Albuquerque, United States, within the medical device sector. A dry powder nebulizer is being developed by the company for targeted drug delivery to the lungs, supporting both local and systemic treatments. The technology incorporates a magnetically responsive element through which mechanical collisions are generated in the dispersion chamber to facilitate aerosolization. Operations focus on advancing inhalation therapies for respiratory applications.
Nob Hill Therapeutics's top competitors include MannKind Corp, OptiNose and Impel NeuroPharma.
Nob Hill Therapeutics offers Inhalation Medicines and Respiratory Therapies.
Nob Hill Therapeutics has 4 investors. Key investors include HHS, Tramway Ventures, TCA Venture Group, and VIC Tech.